Gemcitabine News and Research

RSS
Gemcitabine is the active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used together with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite
Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

An ion pump tested as a possible method to treat malignant brain tumors

An ion pump tested as a possible method to treat malignant brain tumors

The Dream Team opens clinical trial to find better treatment options for pancreatic cancer

The Dream Team opens clinical trial to find better treatment options for pancreatic cancer

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Phase III study of (m)RNA expression did not confer significant advantage for stage II-III lung cancer

Researchers develop an easier way to deliver pancreatic cancer drugs

Researchers develop an easier way to deliver pancreatic cancer drugs

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers identify new way to disrupt process that promotes the growth of pancreatic cancers

Researchers identify new way to disrupt process that promotes the growth of pancreatic cancers

New model can predict the risk of adverse side effects of cancer treatment

New model can predict the risk of adverse side effects of cancer treatment

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Time machine suggests a drug testing approach for pancreatic cancer

Time machine suggests a drug testing approach for pancreatic cancer

Phase II NRG Oncology trial evaluates two regimens for muscle-invasive bladder cancer

Phase II NRG Oncology trial evaluates two regimens for muscle-invasive bladder cancer

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

New treatment may improve the quality of life for patients with mesothelioma

New treatment may improve the quality of life for patients with mesothelioma

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program